[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@yorvel5 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1069757293.png) @yorvel5 yorvel5

yorvel5 posts on X about algs, $algs, $akro, $iva the most. They currently have XX followers and X posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1069757293/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1069757293/c:line/m:interactions.svg)


### Mentions: X [#](/creator/twitter::1069757293/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1069757293/c:line/m:posts_active.svg)


### Followers: XX [#](/creator/twitter::1069757293/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1069757293/c:line/m:followers.svg)


### CreatorRank: undefined [#](/creator/twitter::1069757293/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1069757293/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1069757293/influence)
---

**Social topic influence**
[algs](/topic/algs), [$algs](/topic/$algs), [$akro](/topic/$akro), [$iva](/topic/$iva), [op](/topic/op), [$mdgl](/topic/$mdgl), [$vktx](/topic/$vktx)

**Top assets mentioned**
[Akropolis (AKRO)](/topic/$akro) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx)
### Top Social Posts [#](/creator/twitter::1069757293/posts)
---
Top posts by engagements in the last XX hours

"Citizens reiterated $MDGL Mkt OP/$470 after its 2Q25 survey showed a XX% prescription rate for Rezdiffra (up from XX% in its 1Q survey)" $IVA $AKRO $ALGS $VKTX ETNB SGMT LLY #MASH Citizens in its note to investors said "Our 2Q25 survey shows a XX% prescription rate for Rezdiffra (up from XX% in our 1Q survey) with XX% of patients on paid drug and consistent high persistence; we reiterate our Market Outperform rating and $XXX risk-adjusted DCF-derived price target on Madrigal Pharmaceuticals. Most metrics in our 2Q25 physician survey improved from 1Q which is a good sign coming out of the"  
![@yorvel5 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1069757293.png) [@yorvel5](/creator/x/yorvel5) on [X](/post/tweet/1949508058675093999) 2025-07-27 16:31:55 UTC X followers, XXX engagements